CAT
62
7
HP
45
4
PPL
59
5
ALL
51
8
CMG
67
3
F
47
4
LMT
32
-12
ISRG
76
2
BWA
46
2
ESS
64
4
ZTS
49
2
JNJ
44
3
O
22
2
IFF
56
3
DHI
44
-4
TMO
47
3
GOOG
53
-12
PH
73
3
PEG
67
5
MA
57
2
CAT
62
7
HP
45
4
PPL
59
5
ALL
51
8
CMG
67
3
F
47
4
LMT
32
-12
ISRG
76
2
BWA
46
2
ESS
64
4
ZTS
49
2
JNJ
44
3
O
22
2
IFF
56
3
DHI
44
-4
TMO
47
3
GOOG
53
-12
PH
73
3
PEG
67
5
MA
57
2
Financhill
Back

Maravai LifeSciences Holdings 10K Form

Sell
21

MRVI
Maravai LifeSciences Holdings

Last Price:
5.27
Seasonality Move:
-9.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MRVI News And Ratings

See the #1 stock for the next 7 days that we like better than MRVI

MRVI Financial Statistics

Sales & Book Value

Annual Sales: $288.95M
Cash Flow: $3.55M
Price / Cash Flow: 0
Annual Sales: $2.44
Price / Book: 2.04

Profitability

EPS (TTM): -1.64000
Net Income (TTM): $-224.66M
Gross Margin: $140.2M
Return on Equity: -29.18%
Return on Assets: -14.17%

Maravai LifeSciences Holdings Earnings Forecast

Key Maravai LifeSciences Holdings Financial Ratios

  • The Gross Profit Margin over the past 6 years for MRVI is 48.52%.
  • The Selling, General & Administrative Expenses for MRVI have been equal to 52.39% of Gross Profit Margin.
  • The Research & Development expenses have been 5.98% of Revenue.
  • The Interest Expense is -38.56% of Operating Income.
  • The Net Earning history of MRVI is -41.19% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Maravai LifeSciences Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: MRVI
Website: maravai.com

Debt

Debt-to-Equity Ratio: 1.51
Current Ratio: 10.74
Quick Ratio: 9.6

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MRVI Technical Analysis vs Fundamental Analysis

Sell
21
Maravai LifeSciences Holdings (MRVI) is a Sell

Is Maravai LifeSciences Holdings a Buy or a Sell?